Industry News
Phase II trial suggests therapy should be standard of care for patients facing relapsed or treatment-resistant Hodgkin lymphoma.
"Dense breasts" diagnosis varies widely among radiologists
7/19/2016
The likelihood of a woman being told she has dense breasts varies substantially according to which radiologist interprets her mammogram.
A high-fat Mediterranean diet may protect against breast cancer, diabetes, and cardiovascular events
7/19/2016
According to researchers, a healthy diet can include "a lot of fat." A review of available evidence suggests that a Mediterranean diet with no restrictions on fat intake may reduce a person's risk...
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation has announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) for the treatment of adult...
Medical center reduces blood waste, saves millions with new practices
7/18/2016
By changing practices spanning ordering, transport, and storage of blood, an academic medical center reduces blood use by 30 percent and saves $2 million.
Purpura: What You Need to Know
7/18/2016
Learn all about the causes, symptoms, and treatments for purpura, a skin condition that appears as small purple spots just beneath the surface of the skin.
Mayo Clinic scientists develop new combination therapy for advanced cancers
7/18/2016
A drug combination designed to enhance the immune system's ability to zero in and attack cancer cells has shown a pronounced therapeutic effect against advanced and metastatic cancers in mice...
Hybrid immune cells in early-stage lung cancer spur anti-tumor T cells to action
7/18/2016
The microenvironment of tumors is a mix of cell types, mostly comprised of inflammatory cells.
Scientists trace origin cell of bone and soft tissue tumors, test drug target
7/18/2016
Scientists at Duke Health are part of a team that has discovered a type of cell surrounding blood vessels can also serve as a starting point for sarcoma, a form of cancer that occurs in bones and...
New compounds defeat multi-drug resistant cancer cells
7/15/2016
Researchers find a newly discovered class of molecules - called selenocompounds - can kill multi-drug resistant cancer cells in mice.